Emily S Ruiz, MD, FAAD
SESSIONS
U004 When to Put Down the Scalpel: Non-surgical Therapies for Skin Cancer
Mar 8, 2024
•
7:30 AM - 12:00 AM
•
Room 25B
F028 Respect the Dormant Beast: Optimize Your Management of High-risk Cutaneous SCCs
Mar 8, 2024
•
3:30 PM - 12:00 AM
•
Room 28B
DISCLOSURES
Almirall – Consultant (1099 relationship)(Fees); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Checkpoint Therapeutics – Consultant (1099 relationship)(Fees); Feldan Therapeutics – Consultant (1099 relationship)(Fees); Merck – Investigator(Grants/Research Funding); Regeneron – Advisory Board(Fees), Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees), Consultant (1099 relationship)(Fees);